ATC code H04: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 43: | Line 43: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Revision as of 05:18, 10 February 2025
ATC code H04 is a section of the Anatomical Therapeutic Chemical Classification System (ATC), a system used for the classification of drugs and other medical products. The ATC system is controlled by the World Health Organization (WHO) and is used globally to ensure the consistent classification of medications.
Classification
ATC code H04 is designated for Anti-obesity preparations, excluding diet products. This category includes medications that are used to treat obesity by reducing appetite or increasing the feeling of fullness, thereby helping individuals to lose weight.
Subgroups
The ATC code H04 is further divided into subgroups based on the specific type of anti-obesity medication. These subgroups include:
- H04A - Anti-obesity preparations, excluding diet products
Examples of Medications
Some examples of medications classified under ATC code H04 include:
Mechanism of Action
Anti-obesity medications work through various mechanisms, including:
- Inhibiting the absorption of dietary fats (e.g., Orlistat)
- Suppressing appetite (e.g., Sibutramine, Lorcaserin)
Related Pages
See Also
References
<references group="" responsive="1"></references>
External Links
| ATC codes |
|---|
| H Systemic hormonal preparations, excluding sex hormones and insulins |
| H01 Pituitary and hypothalamic hormones and analogues |
| H02 Corticosteroids for systemic use |
| H03 Thyroid therapy |
| H04 Pancreatic hormones |
| H05 Calcium homeostasis |
|
A
B
C
D
G
H
QI
J
L
M
N
P
R
S
V
|
